Pathogenesis of herpes stromal keratitis - A focus on corneal neovascularization

Progress in Retinal and Eye Research

Volumn 33, Issue 1, 2013, Pages 1-9

  Giménez, Fernanda ^a   Suryawanshi, Amol ^a   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Angiogenesis; Corneal vascularization; Herpes simplex virus; Herpes stromal keratitis

Indexed keywords

AFLIBERCEPT; ANTAGOMIR; ANTIVIRUS AGENT; AUTOANTIGEN; BEVACIZUMAB; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; ECALECTIN; GALECTIN 1; INTERLEUKIN 1; INTERLEUKIN 6; MARIMASTAT; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMID DNA; RESOLVIN E 1; SLIT2 PROTEIN; SMALL INTERFERING RNA; TG 100801; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; ANTIVIRAL THERAPY; CD4+ T LYMPHOCYTE; CORNEA EPITHELIUM; CORNEA NEOVASCULARIZATION; CORNEA TRANSPLANTATION; CYTOKINE PRODUCTION; HERPES SIMPLEX VIRUS 1; HERPES STROMAL KERATITIS; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; VIRUS DETECTION; VIRUS KERATITIS; VIRUS REPLICATION;

ANGIOGENESIS INHIBITORS; ANIMALS; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; HUMANS; KERATITIS, HERPETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84873473505     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2012.07.002     Document Type: Review

References (78)

1. Adams R.H., Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell. Biol. 2007, 8:464-478.
2. Altmann D.M., Blyth W.A. Protection from herpes simplex virus-induced neuropathology in mice showing delayed hypersensitivity tolerance. J. Gen. Virol. 1985, 66(Pt 6):1297-1303.
3. Ambati B.K., Nozaki M., Singh N., Takeda A., Jani P.D., Suthar T., Albuquerque R.J., Richter E., Sakurai E., Newcomb M.T., Kleinman M.E., Caldwell R.B., Lin Q., Ogura Y., Orecchia A., Samuelson D.A., Agnew D.W., St Leger J., Green W.R., Mahasreshti P.J., Curiel D.T., Kwan D., Marsh H., Ikeda S., Leiper L.J., Collinson J.M., Bogdanovich S., Khurana T.S., Shibuya M., Baldwin M.E., Ferrara N., Gerber H.P., De Falco S., Witta J., Baffi J.Z., Raisler B.J., Ambati J. Corneal avascularity is due to soluble VEGF receptor-1. Nature 2006, 443:993-997.
4. Anand S., Majeti B.K., Acevedo L.M., Murphy E.A., Mukthavaram R., Scheppke L., Huang M., Shields D.J., Lindquist J.N., Lapinski P.E., King P.D., Weis S.M., Cheresh D.A. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat. Med. 2010, 16:909-914.
5. Augustin H.G., Koh G.Y., Thurston G., Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell. Biol. 2009, 10:165-177.
6. Azar D.T. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans. Am. Ophthalmol. Soc. 2006, 104:264-302.
7. Bergers G., Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat. Rev. Cancer 2008, 8:592-603.
8. Bergers G., Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 2005, 7:452-464.
9. Billingham R.E., Boswell T. Studies on the problem of corneal homografts. Proc. R. Soc. Lond. B Biol. Sci. 1953, 141:392-406.
10. Biswas P.S., Banerjee K., Zheng M., Rouse B.T. Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein. J. Leukoc. Biol. 2004, 76:868-875.
11. Biswas P.S., Rouse B.T. Early events in HSV keratitis-setting the stage for a blinding disease. Microbes Infect. 2005, 7:799-810.
12. Bouley D.M., Kanangat S., Rouse B.T. The role of the innate immune system in the reconstituted SCID mouse model of herpetic stromal keratitis. Clin. Immunol. Immunopathol. 1996, 80:23-30.
13. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005, 438:932-936.
14. Carmeliet P., Jain R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473:298-307.
15. Carmeliet P., Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature 2005, 436:193-200.
16. Chang J.H., Gabison E.E., Kato T., Azar D.T. Corneal neovascularization. Curr. Opin. Ophthalmol. 2001, 12:242-249.
17. Chung A.S., Ferrara N. Developmental and pathological angiogenesis. Annu. Rev. Cell. Dev. Biol. 2011, 27:563-584.
18. Daheshia M., Feldman L.T., Rouse B.T. Herpes simplex virus latency and the immune response. Curr. Opin. Microbiol. 1998, 1:430-435.
19. Deshpande S., Zheng M., Lee S., Banerjee K., Gangappa S., Kumaraguru U., Rouse B.T. Bystander activation involving T lymphocytes in herpetic stromal keratitis. J. Immunol. 2001, 167:2902-2910.
20. Deshpande S.P., Lee S., Zheng M., Song B., Knipe D., Kapp J.A., Rouse B.T. Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis. J. Virol. 2001, 75:3077-3088.
21. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669-676.
22. Ferrara N., Hillan K.J., Gerber H.P., Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat. Rev. Drug Discov. 2004, 3:391-400.
23. Folkman J. Angiogenesis. Annu. Rev. Med. 2006, 57:1-18.
24. Gangappa S., Deshpande S.P., Rouse B.T. Bystander activation of CD4+ T cells accounts for herpetic ocular lesions. Invest. Ophthalmol. Vis. Sci. 2000, 41:453-459.
25. Ghiasi H., Cai S., Perng G.C., Nesburn A.B., Wechsler S.L. Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring. Br. J. Ophthalmol. 2000, 84:408-412.
26. Hellberg C., Ostman A., Heldin C.H. PDGF and vessel maturation. Recent Results Cancer Res. 2010, 180:103-114.
27. Hoang M.V., Whelan M.C., Senger D.R. Rho activity critically and selectively regulates endothelial cell organization during angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:1874-1879.
28. Jager M.J., Atherton S., Bradley D., Streilein J.W. Herpetic stromal keratitis in mice: less reversibility in the presence of Langerhans cells in the central cornea. Curr. Eye Res. 1991, 10(Suppl.):69-73.
29. Jain R.K. Molecular regulation of vessel maturation. Nat. Med. 2003, 9:685-693.
30. Jones C.A., London N.R., Chen H., Park K.W., Sauvaget D., Stockton R.A., Wythe J.D., Suh W., Larrieu-Lahargue F., Mukouyama Y.S., Lindblom P., Seth P., Frias A., Nishiya N., Ginsberg M.H., Gerhardt H., Zhang K., Li D.Y. Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat. Med. 2008, 14:448-453.
31. Kanangat S., Babu J.S., Knipe D.M., Rouse B.T. HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: selective upregulation of IL-6 gene expression. Virology 1996, 219:295-300.
32. Kim B., Tang Q., Biswas P.S., Xu J., Schiffelers R.M., Xie F.Y., Ansari A.M., Scaria P.V., Woodle M.C., Lu P., Rouse B.T. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am. J. Pathol. 2004, 165:2177-2185.
33. Klemke R.L., Cai S., Giannini A.L., Gallagher P.J., de Lanerolle P., Cheresh D.A. Regulation of cell motility by mitogen-activated protein kinase. J. Cell. Biol. 1997, 137:481-492.
34. Koch A.W., Mathivet T., Larrivée B., Tong R.K., Kowalski J., Pibouin-Fragner L., Bouvrée K., Stawicki S., Nicholes K., Rathore N., Scales S.J., Luis E., del Toro R., Freitas C., Bréant C., Michaud A., Corvol P., Thomas J.L., Wu Y., Peale F., Watts R.J., Tessier-Lavigne M., Bagri A., Eichmann A. Robo4 maintains vessel integrity and inhibits angiogenesis by interacting with UNC5B. Dev. Cell. 2011, 20:33-46.
35. Kurt-Jones E.A., Chan M., Zhou S., Wang J., Reed G., Bronson R., Arnold M.M., Knipe D.M., Finberg R.W. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:1315-1320.
36. Kwong A.D., Frenkel N. The herpes simplex virus virion host shutoff function. J. Virol. 1989, 63:4834-4839.
37. Lee S., Zheng M., Kim B., Rouse B.T. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J. Clin. Invest. 2002, 110:1105-1111.
38. Liesegang T.J. Herpes simplex virus epidemiology and ocular importance. Cornea 2001, 20:1-13.
39. Liu T., Tang Q., Hendricks R.L. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 1996, 70:264-271.
40. Medawar P.B. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 1948, 29:58-69.
41. Mercadal C.M., Bouley D.M., DeStephano D., Rouse B.T. Herpetic stromal keratitis in the reconstituted scid mouse model. J. Virol. 1993, 67:3404-3408.
42. Mulik S., Sharma S., Suryawanshi A., Veiga-Parga T., Reddy P.B., Rajasagi N.K., Rouse B.T. Activation of endothelial roundabout receptor 4 reduces the severity of virus-induced keratitis. J. Immunol. 2011, 186:7195-7204.
43. Mulik S., Xu J., Reddy P.B., Rajasagi N.K., Gimenez F., Sharma S., Lu P.Y., Rouse B.T. Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus. Am. J. Pathol. 2012, 181:525-534.
44. Nagy J.A., Dvorak A.M., Dvorak H.F. VEGF-A and the induction of pathological angiogenesis. Annu. Rev. Pathol. 2007, 2:251-275.
45. Niederkorn J.Y. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat. Immunol. 2006, 7:354-359.
46. Niemialtowski M.G., Rouse B.T. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J. Immunol. 1992, 149:3035-3039.
47. Nirankari V.S. Laser photocoagulation for corneal stromal vascularization. Trans. Am. Ophthalmol. Soc. 1992, 90:595-669.
48. Panoutsakopoulou V., Sanchirico M.E., Huster K.M., Jansson M., Granucci F., Shim D.J., Wucherpfennig K.W., Cantor H. Analysis of the relationship between viral infection and autoimmune disease. Immunity 2001, 15:137-147.
49. Pardali E., Goumans M.J., ten Dijke P. Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell. Biol. 2010, 20:556-567.
50. Pepose J.D. Herpes symplex virus diseases: anterior segment of the eye. Ocular Infection and Immunity, St. Louis 1996, 905-936. J.S. Pepose, G.N. Holland, K.R. Wilhelmus (Eds.).
51. Potter M.D., Barbero S., Cheresh D.A. Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state. J. Biol. Chem. 2005, 280:31906-31912.
52. Qazi Y., Wong G., Monson B., Stringham J., Ambati B.K. Corneal transparency: genesis, maintenance and dysfunction. Brain Res. Bull. 2010, 81:198-210.
53. Rajasagi N.K., Reddy P.B., Suryawanshi A., Mulik S., Gjorstrup P., Rouse B.T. Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. J. Immunol. 2011, 186:1735-1746.
54. Rajasagi N.K., Suryawanshi A., Sehrawat S., Reddy P.B., Mulik S., Hirashima M., Rouse B.T. Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions. J. Immunol. 2012, 188:4631-4643.
55. Remeijer L., Maertzdorf J., Doornenbal P., Verjans G.M., Osterhaus A.D. Herpes simplex virus 1 transmission through corneal transplantation. Lancet 2001, 357:442.
56. Russell R.G., Nasisse M.P., Larsen H.S., Rouse B.T. Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest. Ophthalmol. Vis. Sci. 1984, 25:938-944.
57. Saharinen P., Eklund L., Miettinen J., Wirkkala R., Anisimov A., Winderlich M., Nottebaum A., Vestweber D., Deutsch U., Koh G.Y., Olsen B.R., Alitalo K. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat. Cell. Biol. 2008, 10:527-537.
58. Saishin Y., Takahashi K., Lima e Silva R., Hylton D., Rudge J.S., Wiegand S.J., Campochiaro P.A. VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J. Cell. Physiol. 2003, 195:241-248.
59. Sarangi P.P., Kim B., Kurt-Jones E., Rouse B.T. Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. J. Virol. 2007, 81:11128-11138.
60. Sarangi PP R.B. Herpetic keratitis. Ocular Disease. Mechanisms and Management 2010, 92-97. L. Levin, A. DM (Eds.).
61. Sehrawat S., Suryawanshi A., Hirashima M., Rouse B.T. Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J. Immunol. 2009, 182:3191-3201.
62. Sharma S., Mulik S., Kumar N., Suryawanshi A., Rouse B.T. An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology. J. Virol. 2011, 85:5995-6007.
63. Shimeld C., Hill T., Blyth B., Easty D. An improved model of recurrent herpetic eye disease in mice. Curr. Eye Res. 1989, 8:1193-1205.
64. Streilein J.W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 2003, 3:879-889.
65. Stuart, P.M., Keadle, T.L., 2012. Recurrent Herpetic Stromal Keratitis in Mice: a Model for Studying Human HSK. pp. 1-10.
66. Suryawanshi A., Mulik S., Sharma S., Reddy P.B., Sehrawat S., Rouse B.T. Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. J. Immunol. 2011, 186:3653-3665.
67. Suryawanshi A., Veiga-Parga T., Rajasagi N.K., Reddy P.B., Sehrawat S., Sharma S., Rouse B.T. Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J. Immunol. 2011, 187:1919-1930.
68. Suryawanshi A., Veiga-Parga T., Reddy P.B., Rajasagi N.K., Rouse B.T. IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection. J. Immunol. 2012, 188:3434-3446.
69. Suvas S., Azkur A.K., Kim B.S., Kumaraguru U., Rouse B.T. CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J. Immunol. 2004, 172:4123-4132.
70. Thomas J., Gangappa S., Kanangat S., Rouse B.T. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J. Immunol. 1997, 158:1383-1391.
71. Thomas J., Kanangat S., Rouse B.T. Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis. J. Interferon Cytokine Res. 1998, 18:681-690.
72. Tumpey T.M., Chen S.H., Oakes J.E., Lausch R.N. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 1996, 70:898-904.
73. Tumpey T.M., Cheng H., Yan X.T., Oakes J.E., Lausch R.N. Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10. J. Leukoc. Biol. 1998, 63:486-492.
74. Wuest T.R., Carr D.J. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J. Exp. Med. 2010, 207:101-115.
75. Zhang S.Y., Jouanguy E., Ugolini S., Smahi A., Elain G., Romero P., Segal D., Sancho-Shimizu V., Lorenzo L., Puel A., Picard C., Chapgier A., Plancoulaine S., Titeux M., Cognet C., von Bernuth H., Ku C.L., Casrouge A., Zhang X.X., Barreiro L., Leonard J., Hamilton C., Lebon P., Héron B., Vallée L., Quintana-Murci L., Hovnanian A., Rozenberg F., Vivier E., Geissmann F., Tardieu M., Abel L., Casanova J.L. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007, 317:1522-1527.
76. Zhao Z.S., Granucci F., Yeh L., Schaffer P.A., Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 1998, 279:1344-1347.
77. Zheng M., Deshpande S., Lee S., Ferrara N., Rouse B.T. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J. Virol. 2001, 75:9828-9835.
78. Zheng M., Klinman D.M., Gierynska M., Rouse B.T. DNA containing CpG motifs induces angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:8944-8949.